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Session: Disease & Treatment 99mineralisation ability was conducted to identify whether STIM1 is involved in
osteogenesis. We next investigated the effects of 17b-estradiol on STIM1.
MC3T3-E1 were cultured in the presence of 17b-estradiol and 17b-estradiol inhib-
itor (ICI) while osteogenic induction was conducted. RT-PCR and Western Blot was
used to detect the expression and mRNA transcript levels. To elucidate the under-
lying mechanism of oestrogen on STIM1, we added an inhibitor of PI3K and mTOR to
determine whether this signalling pathway was involved. To investigate the role of
STIM1 in osteoblast differentiation and osteogenesis regulated by 17b-estradiol,
we compared the osteogenic gene markers, ALP activity, and mineralization ability
between STIM1 knockdown and control group in the presence of 17b-estradiol.
Results: The function of the CRAC channel and osteogenic differentiation of BMMSCs
is decreased in postmenopausal osteoporosis patients. Knockdown of STIM1 weak-
ened the osteogenic differentiation and mineralisation of osteoblasts derived
from MC3T3-E1 dramatically. We found that 17b- E2 can promote the expression
and transcription of STIM1 via the PI3K-mTOR signalling pathway. STIM1 also plays
an essential role in osteogenic differentiation of osteoblasts regulated by oestrogen.
Discussion and Conclusion: In summary, we found that the expression of STIM1 is
decreased due to low activity of PI3K-mTOR signalling pathway, because of the low
level of oestrogen after menopause. The decreased expression of STIM1 affects the
differentiation and bone formation. Our study preliminarily clarified the underlying
mechanism of the role of STIM1 on osteogenesis and bone formation, further studies
areneeded toclarifypotentialmechanismsandprovidenew strategies for treatment.
http://dx.doi.org/10.1016/j.jot.2016.06.202516
CHEMOKINES: A POTENTIAL MOLECULAR LINK BETWEEN CHONDROCYTE
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Introduction: Glucocorticoid therapy is known to cause growth plate chondrocyte
damage, bone growth arrest, bone resorption, and bone loss, for which themechanisms remain unclear. The current study aims to identify whether apoptotic
chondrocytes secrete factors that may stimulate osteoclast differentiation. It was
hypothesised that dexamethasone (Dex) will induce chondrocyte apoptosis,
causing increased secretion of chemokines with the capacity to promote osteoclast
recruitment and formation.
Subjects and Methods: The current study utilized an in vitro Dex treatment
model in ATDC5 chondrogenic cells and examined treatment effects on molecu-
lar marker expression, induction of apoptosis, and expression of chemokines and
receptors in differentiated Dex-treated chondrocytes. In addition, ability of pro-
moting osteoclast differentiation in RAW264.7 osteoclast precursor cells was
assessed for conditioned media taken from Dex-treated or -untreated
chondrocytes.
Results: In a time course of chondrogenic culture, the increased type II and X
collagen expression suggests the dynamic chondrocyte differentiation. The signif-
icantly enhanced increased density of apoptotic cells as observed by Hoechst dye
staining as well as markedly increased expression level of Fas-L as examined by
real-time quantitative RT-PCR suggests increased chondrocyte apoptosis following
Dex treatment. Meanwhile, chemokine PCR array analysis of Dex-treated or -un-
treated chondrocytes identified up-regulation of various chemokines in treated
chondrocytes. Chemokine SDF-1 was demonstrated to be the chemokine with
the highest induction following treatment, and its induction was also supported
by conformational RT-PCR. Furthermore, the SDF-1 protein level was also
increased as assayed by ELISA in the conditioned medium of Dex-treated chondro-
cytes. Moreover, it was found that conditioned medium from Dex-treated chondro-
cytes was able to stimulate migration of RAW264.7 cells as well as enhance
formation of TRAP-positively stained RAW264.7 cells. In particular, inhibition of
these promoting effects of the conditioned medium by a neutralising antibody
for SDF-1 was also observed.
Discussion and Conclusion: These findings suggest that Dex treatment can cause
apoptosis of chondrocytes and elevated expression of chemokines by apoptotic
chondrocytes, which may be responsible for enhanced osteoclast migration and
formation, serving as a potential molecular link between chondrocyte apoptosis
and osteoclast differentiation.
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